Synovial sarcoma of the extremities.
From May 1985 to March 1990, 18 cases of Enneking's stage II synovial sarcoma of the extremities were treated by a combination of surgery and CYVADIC chemotherapy with or without radiotherapy. The average follow up was 34.7 months. The estimated 5-year survival rate was 78.4% and the continuously disease-free 5-year survival rate was 44.4%. The results were improved by adequate surgery or chemotherapy when local recurrence or metastases had developed. The combination of surgery and CYVADIC chemotherapy with or without radiotherapy was considered to be an effective method of treating this tumour.
Lee
S Y
SY
Department of Orthopaedic Surgery, Korea Cancer Centre Hospital, Seoul.
Jeon
D G
DG
Kim
S S
SS
D000293:Adolescent; D000328:Adult; D001132:Arm / Q000601:surgery*; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007866:Leg / Q000601:surgery*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D013584:Sarcoma, Synovial / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery*; D015996:Survival Rate